| |
| |
|
| Insider
Information: |
Bienaime Jean Jacques |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
539,056 |
|
|
Indirect Shares
|
247,533 |
|
|
| Direct
Value |
$43,131,983 |
|
|
|
Indirect Value
|
$21,938,850 |
|
|
| Total
Shares |
786,589 |
|
|
| Total
Value |
$65,070,832 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -34.0%
|
-5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
143,601 |
563,203 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-02-27 |
4 |
S |
$90.35 |
$90,350 |
D/D |
(1,000) |
562,203 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-03-05 |
4 |
S |
$85.51 |
$85,510 |
D/D |
(1,000) |
561,203 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-03-06 |
4 |
S |
$86.71 |
$86,713 |
D/D |
(1,000) |
560,203 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
315,228 |
543,482 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
36,100 |
523,956 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-03-15 |
4 |
D |
$87.74 |
$828,002 |
D/D |
(9,437) |
514,519 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-03-10 |
4 |
OE |
$67.81 |
$1,017,150 |
D/D |
15,000 |
502,856 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-03-13 |
4 |
OE |
$67.81 |
$542,480 |
D/D |
8,000 |
495,856 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-04-11 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-04-12 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-05-09 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-05-10 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
167,532 |
487,856 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-03-10 |
4 |
AS |
$92.28 |
$1,384,200 |
D/D |
(15,000) |
487,856 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-03-13 |
4 |
AS |
$90.45 |
$723,600 |
D/D |
(8,000) |
487,856 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-03-15 |
4 |
D |
$83.87 |
$7,146,479 |
D/D |
(85,209) |
474,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-04-11 |
4 |
AS |
$90.99 |
$1,819,800 |
D/D |
(20,000) |
474,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-04-12 |
4 |
AS |
$91.26 |
$1,825,200 |
D/D |
(20,000) |
474,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-05-09 |
4 |
AS |
$81.62 |
$1,632,400 |
D/D |
(20,000) |
474,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-05-10 |
4 |
AS |
$81.14 |
$1,622,800 |
D/D |
(20,000) |
474,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-05-12 |
4 |
OE |
$67.81 |
$3,153,165 |
D/D |
46,500 |
472,713 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-05-09 |
4 |
OE |
$67.81 |
$2,034,300 |
D/D |
30,000 |
456,213 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-05-10 |
4 |
OE |
$67.81 |
$2,034,300 |
D/D |
30,000 |
456,213 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-05-11 |
4 |
OE |
$67.81 |
$2,034,300 |
D/D |
30,000 |
456,213 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
